IMPDH2 Antikörper (AA 5-514) (Biotin)
Kurzübersicht für IMPDH2 Antikörper (AA 5-514) (Biotin) (ABIN7156283)
Target
Alle IMPDH2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 5-514
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Inosine-5\'-monophosphate dehydrogenase 2 protein (5-514AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IMPDH2 (IMP (Inosine 5'-Monophosphate) Dehydrogenase 2 (IMPDH2))
-
Andere Bezeichnung
- IMPDH2
-
Hintergrund
-
Background: Catalyzes the conversion of inosine 5\'-phosphate (IMP) to xanthosine 5\'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors.
Aliases: IMDH2_HUMAN antibody, IMP (inosine monophosphate) dehydrogenase 2 antibody, IMP dehydrogenase 2 antibody, IMP oxireductase 2 antibody, IMPD 2 antibody, IMPD2 antibody, IMPDH 2 antibody, IMPDH II antibody, IMPDH-II antibody, Impdh2 antibody, Inosine 5' monophosphate dehydrogenase 2 antibody, Inosine 5' phosphate dehydrogenase 2 antibody, Inosine monophosphate dehydrogenase type II antibody, Inosine-5''-monophosphate dehydrogenase 2 antibody
-
UniProt
- P12268
-
Pathways
- Ribonucleoside Biosynthetic Process, SARS-CoV-2 Protein Interaktom
Target
-